Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Compass Therapeutics

Clinical trials sponsored by Compass Therapeutics, explained in plain language.

COMPASS Pathways CMPX NASDAQ

COMPASS Therapeutics is a biopharmaceutical company developing psychedelic-based therapies for mental health.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Experimental drug targets Hard-to-Treat neuroendocrine cancers

Disease control Not yet recruiting

This trial tests an experimental drug called CTX-471 in people with advanced neuroendocrine tumors that have a specific marker (NCAM) and have stopped responding to standard treatments. Participants receive the drug by IV every two weeks. The study aims to see if the drug can shr…

Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control

Last updated Jul 08, 2026 00:00 UTC